Show simple item record

dc.contributor.authorKassavou, Aikaterini
dc.contributor.authorCourt, Charlotte A
dc.contributor.authorMirzaei, Venus
dc.contributor.authorBrimicombe, James
dc.contributor.authorEdwards, Simon
dc.contributor.authorSutton, Stephen
dc.date.accessioned2022-01-05T00:31:39Z
dc.date.available2022-01-05T00:31:39Z
dc.date.issued2021-12-20
dc.identifier.issn2296-2565
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/331954
dc.description.abstract<jats:p><jats:bold>Background:</jats:bold> Medication adherence can prevent health risks, but many patients do not adhere to their prescribed treatment. Our recent trial found that a digital intervention was effective at improving medication adherence in non-adherent patients with Hypertension or Type 2 Diabetes; but we do not know how it brought about behavioural changes. This research is a post-trial process evaluation of the mechanism by which the intervention achieved its intended effects.</jats:p><jats:p><jats:bold>Methods:</jats:bold> A mixed methods design with quantitative and qualitative evidence synthesis was employed. Data was generated by two studies. Study 1 used questionnaires to measure the underlying mechanisms of and the medication adherence behaviour, and digital logfiles to objectively capture intervention effects on the process of behaviour change. Multilevel regression analysis on 57 complete intervention group cases tested the effects of the intervention at modifying the mechanism of behaviour change and in turn at improving medication adherence. Study 2 used in depth interviews with a subsample of 20 intervention patients, and eight practise nurses. Thematic analysis provided evidence about the overarching intervention functions and recommendations to improve intervention reach and impact in primary care.</jats:p><jats:p><jats:bold>Results:</jats:bold> Study 1 found that intervention effectiveness was significantly associated with positive changes in the underlying mechanisms of behaviour change (<jats:italic>R</jats:italic><jats:sup>2</jats:sup> = 0.26, <jats:italic>SE</jats:italic> = 0.98, <jats:italic>P</jats:italic> = 0.00); and this effect was heightened twofold when the tailored intervention content and reporting on medication taking (<jats:italic>R</jats:italic><jats:sup>2</jats:sup> = 0.59, <jats:italic>SE</jats:italic> = 0.74, <jats:italic>P</jats:italic> = 0.00) was interested into the regression model. Study 2 suggested that the intervention supported motivation and ability to adherence, although clinically meaningful effects would require very brief medication adherence risk appraisal and signposting to ongoing digitally delivered behavioural support during clinical consultations.</jats:p><jats:p><jats:bold>Conclusion:</jats:bold> This post trial process evaluation used objective methods to capture the intervention effect on the mechanisms of behaviour change to explain intervention effectiveness, and subjective accounts to explore the circumstances under which these effects were achieved. The results of this process evaluation will inform a large scale randomised controlled trial in primary care.</jats:p>
dc.publisherFrontiers Media SA
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleProcess Evaluation of MAPS: A Highly Tailored Digital Intervention to Support Medication Adherence in Primary Care Setting
dc.typeArticle
dc.publisher.departmentDepartment of Public Health And Primary Care, The Primary Care Unit
dc.date.updated2021-12-29T13:34:37Z
prism.publicationDate2021
prism.publicationNameFrontiers in Public Health
prism.startingPage806168
prism.volume9
dc.identifier.doi10.17863/CAM.79403
dcterms.dateAccepted2021-11-30
rioxxterms.versionofrecord10.3389/fpubh.2021.806168
rioxxterms.versionVoR
dc.contributor.orcidKassavou, Aikaterini [0000-0002-6562-4143]
dc.contributor.orcidMirzaei, Venus [0000-0002-4669-9211]
dc.contributor.orcidSutton, Stephen [0000-0003-1610-0404]
dc.identifier.eissn2296-2565
rioxxterms.typeJournal Article/Review
pubs.funder-project-idNational Institute for Health Research (NIHR) (via Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)) (15859 / PB-PG-0215-36032)
cam.issuedOnline2021-12-20
cam.depositDate2021-12-29
pubs.licence-identifierapollo-deposit-licence-2-1
pubs.licence-display-nameApollo Repository Deposit Licence Agreement


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International